---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-013073"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:44:16.339750+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma adds former Congresswoman McMorris Rodgers and Ajay Raju to board, all shareholder proposals passed

## Summary
- All eight director nominees elected at July 22 meeting; new board members are Hon. Cathy McMorris Rodgers and Ajay Raju.
- Shareholders approved all five proposals: auditor ratification, by-law quorum increase to 33⅓%, Nasdaq 20% Rule share issuance, and 75% board vote to remove Chairman.
- Ajay Raju provided $8M seed investment in pre-IPO round; now serves as Chairman/CEO of Raju LLP and co-founder of Avstera Therapeutics.
- Cathy McMorris Rodgers served as first female Chair of House Energy & Commerce Committee; retired from Congress in 2024.
- Dr. Raza Bokhari continues as Executive Chairman and CEO; company focused on clinical-stage pharmaceutical R&D.

## SEC filing metadata
- accession: 0001062993-25-013073
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325013073/0001062993-25-013073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325013073/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-013073
- JSON: https://secwatch.observer/filing/0001062993-25-013073.json
- Plain text: https://secwatch.observer/filing/0001062993-25-013073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
